Abcam, up 4.9%, today, announced that it has appointed Luba Greenwood as a Non-Executive Director, with immediate effect. Darktrace, down 24.8%, in its final results for the year ended 30 June 2022, announced that revenues rose to $415.5m from $285.1m. Profit before tax stood at $5.3m compared to a loss of $143.9m. For FY 2023 Darktrace continues to expect free cash flow to be approximately 60% to 65% of FY 2023 adjusted EBITDA.
1Spatial, up 5.1%, announced that it has won a seven-year contract worth $1.2m from the State of Arkansas for its Next Generation 911 (NG911) solution, the eighth US State to select the solution. Additionally, it has also been chosen as a vendor for conflation solutions within its Traffic Data Marketplace (TDM), by the Eastern Transportation Coalition (ETC), a partnership of 18 US east coast States and Washington DC, and has secured its first contract through the marketplace, for $400k with Massachusetts Department of Transportation.
Feedback, up 4.3%, announced that it has won a 12-month contract to supply its CDC solution, which would enable the expansion of the current CDC pilot in Sussex to more GP practises and the adoption of additional clinical pathways.
Quixant, 1.6%, in its interim results for the six months ended 30 June 2022, announced that revenues rose 46% to $53.3m from $36.5m recorded in the same period a year ago. Profit before tax widened to $2.8m from $0.8m. Net cash stood at $12.0m, down from $17.6m in 2021.
Bango, up 1.5%, today, announced that it expects to release its interim results for the six months ended 30 June 2022 on 29 September 2022.
Checkit, down 4.7%, announced that its Chief Executive Officer, Kit Kyte and Chief Financial Officer, Greg Price would give a live presentation on the company’s interim results through the Investor Meet Company platform on 15 September 2022 at 12:00pm BST.
Sareum Holdings, down 1.5%, today, announced that Sotyktu™ (deucravacitinib), a first-in-class oral, selective, allosteric tyrosine kinase 2 inhibitor, has been approved by the US Food and Drug Administration for the treatment of adults with plaque psoriasis.
Oracle Power, unchanged at 0.3p, announced that it has been selected by the Korea Trade-Investment Promotion Agency (KOTRA) to build a strategy to register carbon credits within Pakistan.
UK markets closed higher last week, after Britain’s new Prime Minister Liz Truss unveiled a strategy to combat rising energy prices. On the macro front, UK house prices rebounded in August. Meanwhile, the RICS house price declined in July, reaching its lowest level since January 2021 while the nation’s construction activity contracted for a second straight month in August, amid ongoing economic uncertainty. Additionally, UK’s services sector’s growth slowed in August, while the nation’s private sector activity contracted for the first time since February 2021 in August, indicating signs of recession. The FTSE 100 index advanced 1% to settle at 7,351.1, while the FTSE AIM 100 index rose 2.1% to close at 4,218.3. Meanwhile, the FTSE techMARK 100 index gained 2.1% to end at 6,184.4.
US markets ended higher in the previous week, as investors shrugged off concerns over higher interest rates. On the data front, the US ISM services activity grew at a faster rate for a second straight month in August, driven by robust order growth and employment, while the nation’s goods and services trade deficit narrowed to a 9-month low in July, as imports fell. Additionally, the US initial claims declined to a 3-month low in the week ended 02 September 2022. Moreover, the US consumer credit grew moderately in July. The DJIA index rose 2.7% to end at 32,151.7, while the NASDAQ index gained 4.1% to close at 12,112.3.
